肥満の女性は妊娠中に体重を増やす必要はない(Women with obesity do not need to gain weight during pregnancy)

ad

2024-04-02 カロリンスカ研究所(KI)

Woman holding a pregnancy test.Photo: Getty Images

カロリンスカ研究所の新研究では、肥満女性の妊娠中の体重増加ガイドラインに疑問が投げかけられています。BMIが30〜39.9の肥満1および2クラスの女性に対して、現在のガイドライン以下の体重増加は健康リスクを増加させず、BMIが40を超える肥満3クラスの女性にとっては有益である可能性が示されました。この研究は、妊娠中の肥満女性に対するガイドラインの再評価を促すものです。

<関連情報>

クラス1、2、3肥満の妊娠における低体重増加または体重減少の安全性:集団ベースのコホート研究 Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study

Kari Johansson, PhD ;Prof Lisa M Bodnar, PhD;Prof Olof Stephansson, MD;Prof Barbara Abrams, DrPH;Jennifer A Hutcheon, PhD
The Lancet  Published:March 28, 2024
DOI:https://doi.org/10.1016/S0140-6736(24)00255-1

Summary

Background
There are concerns that current gestational weight gain recommendations for women with obesity are too high and that guidelines should differ on the basis of severity of obesity. In this study we investigated the safety of gestational weight gain below current recommendations or weight loss in pregnancies with obesity, and evaluated whether separate guidelines are needed for different obesity classes.

Methods
In this population-based cohort study, we used electronic medical records from the Stockholm–Gotland Perinatal Cohort study to identify pregnancies with obesity (early pregnancy BMI before 14 weeks’ gestation ≥30 kg/m2) among singleton pregnancies that delivered between Jan 1, 2008, and Dec 31, 2015. The pregnancy records were linked with Swedish national health-care register data up to Dec 31, 2019. Gestational weight gain was calculated as the last measured weight before or at delivery minus early pregnancy weight (at <14 weeks’ gestation), and standardised for gestational age into z-scores. We used Poisson regression to assess the association of gestational weight gain z-score with a composite outcome of: stillbirth, infant death, large for gestational age and small for gestational age at birth, preterm birth, unplanned caesarean delivery, gestational diabetes, pre-eclampsia, excess postpartum weight retention, and new-onset longer-term maternal cardiometabolic disease after pregnancy, weighted to account for event severity. We calculated rate ratios (RRs) for our composite adverse outcome along the weight gain z-score continuum, compared with a reference of the current lower limit for gestational weight gain recommended by the US Institute of Medicine (IOM; 5 kg at term). RRs were adjusted for confounding factors (maternal age, height, parity, early pregnancy BMI, early pregnancy smoking status, prepregnancy cardiovascular disease or diabetes, education, cohabitation status, and Nordic country of birth).

Findings
Our cohort comprised 15 760 pregnancies with obesity, followed up for a median of 7·9 years (IQR 5·8–9·4). 11 667 (74·0%) pregnancies had class 1 obesity, 3160 (20·1%) had class 2 obesity, and 933 (5·9%) had class 3 obesity. Among these pregnancies, 1623 (13·9%), 786 (24·9%), and 310 (33·2%), respectively, had weight gain during pregnancy below the lower limit of the IOM recommendation (5 kg). In pregnancies with class 1 or 2 obesity, gestational weight gain values below the lower limit of the IOM recommendation or weight loss did not increase risk of the adverse composite outcome (eg, at weight gain z-score –2·4, corresponding to 0 kg at 40 weeks: adjusted RR 0·97 [95% CI 0·89–1·06] in obesity class 1 and 0·96 [0·86–1·08] in obesity class 2). In pregnancies with class 3 obesity, weight gain values below the IOM limit or weight loss were associated with reduced risk of the adverse composite outcome (eg, adjusted RR 0·81 [0·71–0·89] at weight gain z-score –2·4, or 0 kg).

Interpretation
Our findings support calls to lower or remove the lower limit of current IOM recommendations for pregnant women with obesity, and suggest that separate guidelines for class 3 obesity might be warranted.

Funding
Karolinska Institutet and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

ad

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました